Top

International Urogynecology Journal

Published in:

01-07-2018 | Original Article

Comparison of adjustable continence therapy periurethral balloons and artificial urinary sphincter in female patients with stress urinary incontinence due to intrinsic sphincter deficiency

Authors: Lucas Freton, Lauranne Tondut, Isabelle Enderle, Juliette Hascoet, Andrea Manunta, Benoit Peyronnet

Published in: International Urogynecology Journal | Issue 7/2018

Abstract

Introduction and hypothesis

The objective was to compare the outcomes of the ACT® device with those of the artificial urinary sphincter (AUS) AMS 800 in the treatment of stress urinary incontinence (SUI) due to sphincter deficiency in women.

Methods

All the women who underwent surgical treatment for SUI due to intrinsic sphincter deficiency from 2007 to 2017 were included in a single-center retrospective study. The primary endpoint was the functional outcome. Perioperative functional parameters of the two groups were compared.

Results

Twenty-five patients underwent an ACT® implantation and 36 an AUS implantation. Patients in the AUS group were younger (62.9 vs 70.4 years; p = 0.03) with less comorbidity (ASA Score = 3 in 12.1% vs 33.3%; p = 0.005). Operative time and hospital stay were shorter in the ACT® group (45.7 vs 206.1 min; p < 0.001; 1.7 vs 7 days; p < 0.001 respectively). There was a higher rate of intraoperative complications in the AUS group (47% vs 8%; p < 0.001) but the rates of postoperative complications were similar between both groups. The ACT® was associated with an increased risk of urinary retention (20% vs 2.8%; p = 0.04). Results were in favor of AUS for: decrease in USP stress incontinence subscore (−7.6 vs −3.2; p < 0.001), number of pads per 24 h (− 4.6 vs −2.3; p = 0.002), PGII scale (PGII = 1: 61.1% vs 12%; p < 0.001), and cure rate (71.4% vs 21.7%; p < 0.001).

Conclusions

In the present series, keeping in mind the significantly different baseline characteristics, AUS implantation was associated with better functional outcomes than the ACT® in female patients with SUI due to intrinsic sphincter deficiency, but with a higher intraoperative complications rate, longer operative time, and a longer stay.

Available only for authorised users

Cour F, Le Normand L, Lapray J-F, Hermieu J-F, Peyrat L, Yiou R, et al. Intrinsic sphincter deficiency and female urinary incontinence. Prog Urol. 2015;25(8):437–54. https://doi.org/10.1016/j.purol.2015.03.006.CrossRefPubMed

Costa P, Poinas G, Naoum KB, Bouzoubaa K, Wagner L, Soustelle L, et al. Long-term results of artificial urinary sphincter for women with type III stress urinary incontinence. Eur Urol. 2013;63(4):753–8. https://doi.org/10.1016/j.eururo.2012.03.008.CrossRefPubMed

Lo T-S, Pue LB, Tan YL, Pei-Ying W. Risk factors for failure of repeat midurethral sling surgery for recurrent or persistent stress urinary incontinence. Int Urogynecol J. 2016;27(6):923–31. https://doi.org/10.1007/s00192-015-2912-5.CrossRefPubMed

Chartier-Kastler E, Van Kerrebroeck P, Olianas R, Cosson M, Mandron E, Delorme E, et al. Artificial urinary sphincter (AMS 800) implantation for women with intrinsic sphincter deficiency: a technique for insiders? BJU Int. 2011;107(10):1618–26. https://doi.org/10.1111/j.1464-410X.2010.09610.x.CrossRefPubMed

Nadeau G, Herschorn S. Management of recurrent stress incontinence following a sling. Curr Urol Rep. 2014;15(8):427. https://doi.org/10.1007/s11934-014-0427-0.CrossRefPubMed

Vayleux B, Luyckx F, Thélu S, Rigaud J, Bouchot O, Karam G, et al. Adjustable continence therapy in women, middle term follow-up and a new technique for balloon positioning. Prog Urol. 2010;20(7):520–6. https://doi.org/10.1016/j.purol.2010.01.010.CrossRefPubMed

Phé V, Nguyen K, Rouprêt M, Cardot V, Parra J, Chartier-Kastler E. A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA). World J Urol. 2014;32(2):495–505. https://doi.org/10.1007/s00345-013-1117-0.CrossRefPubMed

Kocjancic E, Crivellaro S, Ranzoni S, Bonvini D, Grosseti B, Frea B. Adjustable continence therapy for severe intrinsic sphincter deficiency and recurrent female stress urinary incontinence: long-term experience. J Urol. 2010;184(3):1017–21. https://doi.org/10.1016/j.juro.2010.05.024.CrossRefPubMed

Peyronnet B, Vincendeau S, Tondut L, Bensalah K, Damphousse M, Manunta A. Artificial urinary sphincter implantation in women with stress urinary incontinence: preliminary comparison of robot-assisted and open approaches. Int Urogynecol J. 2016;27(3):475–81. https://doi.org/10.1007/s00192-015-2858-7.CrossRefPubMed

10.

Haab F, Richard F, Amarenco G, Coloby P, Arnould B, Benmedjahed K, et al. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the urinary symptom profile (USP) questionnaire. Urology. 2008;71(4):646–56. https://doi.org/10.1016/j.urology.2007.11.100.CrossRefPubMed

11.

Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30. https://doi.org/10.1002/nau.20041.CrossRefPubMed

12.

Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.CrossRefPubMedPubMedCentral

13.

Mitropoulos D, Artibani W, Graefen M, Remzi M, Rouprêt M, Truss M. European Association of Urology guidelines panel. “Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations”. Eur Urol. 2012;61(2):341–9. https://doi.org/10.1016/j.eururo.2011.10.033.CrossRefPubMed

14.

Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003;189(1):98–101.CrossRefPubMed

15.

Abrams P, Cardozo L, Khoury S, Wein A. Incontinence. 5th edition. Bristol: International Consultation on Urological Diseases; 2013.

16.

DeLancey JOL. The pathophysiology of stress urinary incontinence in women and its implications for surgical treatment. World J Urol. 1997;15(5):268–74. https://doi.org/10.1007/BF02202011.CrossRefPubMed

17.

Petros PEP, Ulmsten UI, Papadimitriou J. The autogenic ligament procedure: a technique for planned formation of an artificial neo-ligament. Acta Obstet Gynecol Scand. 1990;69(S153):43–51. https://doi.org/10.1111/j.1600-0412.1990.tb08031.x.CrossRef

18.

McGuire EJ. Diagnosis and treatment of intrinsic sphincter deficiency. Int J Urol. 1995;2(Suppl 1):7–10; discussion 16–18PubMed

19.

Kobashi KC, Albo ME, Dmochowski RR, Ginsberg S, Goldman HB, Gomelsky A, Kraus SR, Sandhu JS, Shepler T, Treadwell JR, Vasavada S, Lemack GE. AUA guidelines. http://www.auanet.org/guidelines/stress-urinary-incontinence-(sui)-new-(aua/sufu-guideline-2017).

20.

Burkhard FC, Bosch JLHR, Cruz F, Lemack GE, Nambiar AK, Thiruchelvam N, Tubaro A, Ambühl D, Bedretdinova D, Farag R, Rozenberg BB. EAU guidelines https://uroweb.org/guideline/urinary-incontinence/.

21.

Bruyère F, Sotto A, Escaravage L, Cariou G, Mignard JP, Coloby P, Hoznek A, Bernard L, Boiteux JP, Thibault M, Soussy CJ, Bugel H; Infectious Disease Committee of the French Association of Urology (AFU). [Recommendations of the Infectious Disease Committee of the French Association of Urology (AFU): antibiotic prophylaxis for urological procedures]. Prog Urol. 2010;20(2):101–8.CrossRefPubMed

22.

Fournier G, Callerot P, Thoulouzan M, Valeri A, Perrouin-Verbe M-A. Robotic-assisted laparoscopic implantation of artificial urinary sphincter in women with intrinsic sphincter deficiency incontinence: initial results. Urology. 2014;84(5):1094–8. https://doi.org/10.1016/j.urology.2014.07.013.CrossRefPubMed

23.

Riss P, Kargl J. Quality of life and urinary incontinence in women. Maturitas. 2011;68(2):137–42. https://doi.org/10.1016/j.maturitas.2010.11.006.CrossRefPubMed

24.

Siddiqui ZA, Abboudi H, Crawford R, Shah S. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review. Int Urogynecol J. 2017;28(9):1275–84. https://doi.org/10.1007/s00192-017-3278-7.CrossRefPubMed

Title: Comparison of adjustable continence therapy periurethral balloons and artificial urinary sphincter in female patients with stress urinary incontinence due to intrinsic sphincter deficiency
Authors: Lucas Freton
Lauranne Tondut
Isabelle Enderle
Juliette Hascoet
Andrea Manunta
Benoit Peyronnet
Publication date: 01-07-2018
Publisher: Springer London
Published in: International Urogynecology Journal / Issue 7/2018
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-017-3544-8

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Comparison of adjustable continence therapy periurethral balloons and artificial urinary sphincter in female patients with stress urinary incontinence due to intrinsic sphincter deficiency

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2018

What is the true catheterization rate after intravesical onabotulinumtoxinA injection?

The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid

Laparoscopic implantation of electrodes for bilateral neuromodulation of the pudendal nerves and S3 nerve roots for treating pelvic pain and voiding dysfunction

Commentary on “Comparison of adjustable continence therapy periurethral balloons and artificial urinary sphincter in female patients with stress urinary incontinence due to intrinsic sphincter deficiency”

Reply to the letter to the editor

Lower urinary tract symptoms that predict microscopic pyuria